AMGEN

AMGEN

Displaying 10 out of 27 results

  1. File photo of an Amgen sign at the company's office in South San Francisco

    US court upholds Amgen patents on arthritis drug Enbrel

    A U.S. judge on Friday said patents relating to the Amgen Inc's blockbuster rheumatoid arthritis drug Enbrel were valid, denying a challenge by ...
  2. File photo of an Amgen sign at the company's office in South San Francisco

    Amgen quarterly results beat estimates, but revenue dips 3per cent

    Amgen Inc on Tuesday said its second-quarter revenue fell 3per cent due to more competition for its older off-patent drugs, but rising sales of ...
  3. Used blister packets that contained medicines, tablets and pills are seen, in this picture illustra

    US drugmakers file lawsuit against requiring drug prices in TV ads

    U.S. drugmakers on Friday filed a lawsuit to prevent the companies from disclosing the list price of prescription drugs in direct-to-consumer ...
  4. New Content Item

    Sanofi loses German patent case against Amgen over cholesterol drug

  5. FILE PHOTO: Lilly logo on a wall of Lilly France, part of Eli Lilly and Co, in Fegersheim, France

    Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

    Eli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical Industries Ltd in attracting new patients to a new ...
  6. Amgen's migraine treatment, Aimovig, which has been prescribed to more than 200,000 patients s

    The obscure advisory committees at the heart of the US drug pricing debate

    Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries.
  7. New Content Item

    Amgen's postmenopausal osteoporosis drug gets FDA approval

  8. FILE PHOTO: File photo of an Amgen sign at the company's office in South San Francisco

    Novartis, Amgen in dispute over migraine drug partnership

    Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotechnology company of trying to back out of agreements to jointly ...